+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hematologic and oncologic diseases and the liver

Hematologic and oncologic diseases and the liver

Clinics in Liver Disease 15(1): 69-87

Malignant and nonmalignant disorders may affect the liver, causing signs and symptoms ranging from mild increases of liver tests to fulminant hepatic failure. This article discusses the most common hematologic and oncologic disorders and their effect on the liver. The section on nonmalignant hematologic disorders includes the anemias, paroxysmal nocturnal hemoglobinuria, disseminated intravascular coagulation, malaria, Banti syndrome, the porphyrias, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Malignant hematologic conditions include leukemias, lymphomas, and myeloproliferative disorders. Other conditions causing portal hypertension and hepatic metastases are also discussed. The most commonly encountered hepatic manifestations of hematologic and oncologic disorders are reviewed.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053506412

Download citation: RISBibTeXText

PMID: 21111994

DOI: 10.1016/j.cld.2010.09.013

Related references

Visual diagnosis of hematologic and oncologic diseases. Emergency Medicine Clinics of North America 11(2): 273-335, 1993

Skin changes associated with hematologic and oncologic diseases in children. New York State Journal of Medicine 92(6): 256-261, 1992

Is laparoscopic splenectomy appropriate for the management of hematologic and oncologic diseases?. Surgical Endoscopy 10(4): 387-388, 1996

Clinical relevance of immunotyping of oncologic and hematologic diseases. Onkologie 10(3): 114-120, 1987

Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 39(7): 763-771, 1999

Therapy of defects in the oral mucosa in patients with hematologic or oncologic diseases. Krankenpflege Journal 34(3): 88-91, 1996

Search for bone marrow donors for patients with hematologic-oncologic diseases. Beitrage Zur Infusionstherapie 26: 214-216, 1990

Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. Journal of Pediatric Hematology/Oncology 31(7): 505-508, 2009

Lactate dehydrogenase isoenzymes in the blood cells of hematologic and oncologic diseases. Wiener Medizinische Wochenschrift 126(32-35): 473-478, 1976

Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases. Klinische Padiatrie 213(Suppl. 1): A103-A105, 2001

Umbilical cord blood transplants: treatment for selected hematologic and oncologic diseases. Journal of Perinatal and Neonatal Nursing 11(3): 19-29; Quiz 98-9, 1997

Prevalence of hepatitis C virus in poly-transfused patients with hematologic and oncologic diseases. Infusionstherapie und Transfusionsmedizin 19(1): 19-22, 1992

Transient elevation of interleukin 2 receptors following chemotherapy in children with hematologic/oncologic diseases. Jikeikai Medical Journal 40(2): 163-170, 1993

Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases. Klinische Padiatrie 213(Suppl. 1): A88-102, 2001

Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases. Journal of Korean Medical Science 30(8): 1121-1128, 2015